Table 1

Stimulation of purified sGC in the presence and absence of DTT by the NO donor SNP. YC-1 and the ortho-. meta- and para-PALs with Mg2+ as cofactor. Shown are the x-fold stimulations versus basal specific activity of SNP (1 μM). YC-1 (100 μM, 10 μM, 1 μM and 1 μM YC-1 in combination with 1μM SNP) and the different PALs (100 μM, 10 μM, 1 μM and 1 μM PAL in combination with 1 μM SNP). The data presented represent the mean ± SEM out of four independent experiments performed in duplicate.

Stimulation of purified sGC [fold increase vs. basal activity ± SEM] (basal specific activity [nmol/mg/min])

Stimulator
Concentration
+ DTT
-DTT

Basal

1.0 ± 0.1 (64 ± 8)
1.0 ± 0.2 (150.8 ± 33.4)
SNP
1 μM
82.3 ± 10.5
17.1 ± 2.2

100 μM
45.9 ± 7.7
44.4 ± 4.8
YC-1
10 μM
4.5 ± 0.8
7.0 ± 1.7

1 μ M
2.0 ± 0.4
1.5 ± 0.2
YC-1 + SNP
1 μM + 1 μM
98.4 ± 17.3
20.6 ± 3.6

100 μM
14.4 ± 1.6
21.4 ± 4.2
ortho-PAL
10 μM
2.9 ± 1.5
3.1 ± 0.6

1 μ M
2.1 ± 1.0
1.0 ± 0.1
ortho-PAL + SNP
1 μM + 1 μM
85.7 ± 11.4
15.8 ± 2.0

100 μM
54.7 ± 10.2
56.1 ± 0.1
meta-PAL
10 μM
21.3 ± 7.1
23.3 ± 4.1

1 μ M
4.5 ± 1.0
4.9 ± 0.4
meta-PAL + SNP
1 μM + 1 μM
185.6 ± 72.6
39.0 ± 5.6

100 μM
36.6 ± 3.5
30.2 ± 4.5
para-PAL
10 μM
15.3 ± 2.7
17.3 ± 1.9

1 μM
3.5 ± 0.4
3.8 ± 0.3
para-PAL + SNP
1 μM + 1 μM
229.1 ± 33.6
50.6 ±5.5

Becker et al. BMC Pharmacology 2001 1:13   doi:10.1186/1471-2210-1-13